Report Code: A13229 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Remdesivir Market
Request Now !Remdesivir Market Outlook 2030
Remdesivir is a broad spectrum anti-viral medication which was firstly developed by Gilead Sciences. It is administered through injection into the vein. Remdesivir is a prodrug of nucleotide. In COVID-19 pandemic remdesivir was authorized for emergency treatment of COVID-19 around the 50 countries as per the recommendation of WHO in November 2020. Originally remdesiver is used in treatment of hepatitis C, Ebola virus, and Marburg virus infections. Moreover, remdesivir can be used in treatment of respiratory infections, feline infections, and arenaviruses. Nausea, liver infection, low blood pressure, and vomiting are common adverse effects of remdesivir.
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the remdesivir market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, Jubilant Life Sciences announced launch of remdesivir for injection 100mg vial under the brand name JUBI-R. This injection can be used in treatment of COVID-19.
In 2020, Mylan announced commercial launch of remedesivir for injection under the brand name DESREMTM in India. This is a licensed drug for treatment of COVID-19 patients.
In 2020, Zydus Cadila announced launch of remdesivir lyophilised injection 100mg/vial. This injection can be used for patients suffering from SARS-CoV2.
Key Benefits of the Report
Questions Answered in the Remdesivir Market Report                                  Â
Remdesivir Market Report Highlights
Aspects | Details |
---|---|
By Dosage |
|
By Form |
|
By Application |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Viatris Pharmaceuticals Ltd. (Mylan Laboratories India Pvt. Ltd.), Jubilant Life Sciences Ltd., Sun Pharmaceuticals Industries Ltd., Eva Pharma Pvt. Ltd., Zydus Cadila Healthcare Ltd., Cipla Ltd., Pfizer Ltd., Dr. Reddy’s Laboratories Ltd., Hetero Labs Pvt. Ltd., Gilead Sciences India Private Limited |
Start reading.
This Report and over 67,566+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers